Junghof, Julia https://orcid.org/0000-0002-2674-4361
Kogure, Yuta
Yu, Tian
Verdugo-Sivianes, Eva MarĂa https://orcid.org/0000-0002-0922-0371
Narita, Megumi https://orcid.org/0000-0002-8198-4042
Lucena-Cacace, Antonio https://orcid.org/0000-0002-1181-2683
Yoshida, Yoshinori https://orcid.org/0000-0001-5511-9090
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP19bm0804008)
Japan Agency for Medical Research and Development (JP20bm0204003)
Japan Agency for Medical Research and Development (JP20bm0804022)
Japan Agency for Medical Research and Development (JP19mk0104117)
Japan Agency for Medical Research and Development (JP19bk0104095)
Japan Agency for Medical Research and Development (JP19bm0104001)
MEXT | Japan Society for the Promotion of Science (17H04176)
MEXT | Japan Society for the Promotion of Science (21H02912)
MEXT | Japan Society for the Promotion of Science (20K17078)
Fondation Leducq (18CVD05)
iPS Cell Research Fund, SECOM Science and Technology Foundation
Article History
Received: 2 March 2021
Accepted: 20 December 2021
First Online: 2 February 2022
Competing interests
: J.J., T.Y., Y.K., E.M.V.-S., M.N. and A.L.-C. declare no competing interest. Y.Y. is a scientific advisor of Orizuru Therapeutics.